Search for Clinical Trial Results
Agranulocytosis - 258 Studies Found
Status | Study |
Completed |
Study Name: A Study of Empirical Antifungal Therapy With Itraconazole Condition: Neutropenia Date: 2012-10-11 Interventions: Drug: Itraconazole Itraconazole intravenous (IV) 200 mg twice daily for 2 days, a total of 4 doses and t |
Completed |
Study Name: Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia Condition: Chemotherapy Induced Neutropenia Date: 2012-01-19 Interventions:
|
Completed |
Study Name: The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies Condition: Neutropenia Date: 2012-08-16 |
Completed |
Study Name: Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia Condition: Breast Cancer Date: 2012-07-27 Interventions: Drug: GCSF administration on days 8 and 12 after chemotherapy |
Completed |
Study Name: Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients Condition: Neutropenia Date: 2012-07-02 Interventions: Drug: Pegfilgrastim Single SC injection of the appropriate dose of drug ranging from 30 mcg/kg to 200 mc |
Completed |
Study Name: Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents Condition:
|
Completed |
Study Name: Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy Condition: Neutropenia Date: 2012-03-29 Interventions:
|
Completed |
Study Name: Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation Condition:
Date: 2011-08-09 Interventions: Drug: micafungin Eligible patients who provided informed consent form will be administered micafungin at |
Completed |
Study Name: GCPGC in Chemotherapy-induced Neutropenia Condition: Chemotherapy Induced Neutropenia Date: 2011-02-06 Interventions:
|
Terminated |
Study Name: SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients Condition: Leukemia Date: 2010-10-14 Interventions: Drug: filgrastim 5 mcg/kg (rounded to 300 mcg or 480 mcg) |